✦ Hormonal care made easy

Eat in sync with your hormonal cycle

Stabilize energy, mood, and productivity with science-backed nutrition aligned to your 28-day cycle. Personalized by AI, supported by a community.

✅ 120+ women interviewed✅ 96% cycle-aware🔒 Your data stays yours

📱 Member — open the app

📈 Admin & Investor Hub

🛠️ Admin console

A tailored solution for all women

Everything in one cycle-aware app

🗓️

Daily guided experience

Your phase, and exactly what to eat and how to train today.

🥗

Phase-synced nutrition

NutriLog, Nutri Basics and recipes that adapt to your cycle.

📈

Cycle alignment score

Track mood, energy and how well you're syncing over time.

👥

Community

Clinically-reviewed articles and women on the same journey.

Business model

Simple, fair pricing

Free

€0

✅ Cycle tracking
✅ Daily focus tips
✅ Community

Start free

Premium

€5.99/mo

✅ AI meal plans
✅ Full analytics
✅ Phase workouts

Open app

For employers

€35–50/yr

✅ Per employee
✅ Wellbeing programs
✅ Private aggregates

Learn more

Built by women, for women

The team

Pilar Gonzalez

CEO · Co-Founder

Strategy consulting & research

Lucia Cebrian

COO · Co-Founder

UX/UI & product

Maria Paula Garzon

CMO · Co-Founder

Branding & marketing

Be first to sync your cycle

Join the waitlist — we'll let you know the moment NutriSync launches.

NUTRISYNC 🪶

Admin & Investor Hub

Confidential. Enter your access PIN / password.

Demo PIN: nutrisync2026

CONFIDENTIAL · NUTRISYNC INVESTOR & ADVISORY MATERIAL · DO NOT DISTRIBUTE

NUTRISYNC

The Business Case

The full investor presentation (June 2026) as a web page — mission, market, the adaptive cycle intelligence, traction, model, deep-tech moats, financials and the ask. Plus the rebuilt, validation-led financial model.

$5.07Bmenstrual-health market '30

€350Kraising · 18-mo runway

M35profitability

15.5K+Y3 paying users

🛠️ Admin MIS console

📄 Pitch deck (PDF) 📊 Rebuilt financial model (XLSX) 📑 Review & assumptions (DOCX) 📑 Industry benchmarks (DOCX)

Financial model · rebuild

Intent of the rebuild of the business case

The intent of this rebuild is to turn the financial model from a directional forecast into a more credible, investor-ready planning tool.

The original model showed a promising business opportunity, but some assumptions were too aggressive, some outputs were hardcoded, and the scenarios did not fully flow from a single set of assumptions. That made it harder to test the business properly or defend the numbers under investor scrutiny.

The rebuilt model is designed to make the forecast more transparent, flexible, and evidence-led. It links the scenarios to clear assumptions, models growth through a monthly user funnel, separates B2C and B2B revenue logic, and distinguishes between assumptions supported by market references and assumptions that still need validation through real user data.

The purpose is not to make the numbers look bigger. It is to make them more believable.

A stronger financial model should help answer three investor questions clearly:

How does NutriSync acquire, convert, and retain users?
Which assumptions are already supported by market evidence?
Which assumptions still need to be proven through pilots, waitlist data, retention data, or paid acquisition tests?

By making the Conservative case less aggressive and treating unproven assumptions as validation targets, the model becomes more useful as a decision-making tool. It can now support fundraising conversations, but also help the team identify what must be tested before scaling.

In short, the intent is to move the model from optimistic projection to defensible growth plan.

Rebuilt model · scenarios

Three scenarios from one set of assumptions

Formula-linked from the Assumptions tab. End-of-Year-3 outputs (a deliberately less aggressive Conservative case).

Metric (End of Year 3)	Conservative	Realistic	Ambitious
Total paying users	~5,870	~26,980	~93,870
Total annual revenue	~€316K	~€1.30M	~€3.4M+
ARR at year end	~€379K	~€1.75M	~€4.6M+
Gross margin	~83%	~83%	~84%
Financing modelled (seed + Series A)	€350K + €1.2M	€350K + €1.8M	€350K + €2.5–6M

Figures from NUTRISYNC_financial_model_rebuilt.xlsx (Summary tab). Financing inflows are shown separately and are not treated as operating revenue.

Validation targets

What must be proven before pitching assumptions as fact

Assumption	Original model	Industry reality	Target to prove
Monthly free→paid conversion	18% flat	2–7% (top quartile)	≥3% (conservative)
Monthly B2C churn (Y1)	10% ("conservative")	12–15% is the true downside; 66% of health apps abandoned in 90 days	Stress-test 12–15%
Wearable churn reduction	50%	Structurally sound (hardware lock-in)	≥20% reduction in 90-day cohorts
Waitlist → paid conversion	25–42%	High-intent justified, but unproven at scale	Track real waitlist cohort
B2B contracts	Smooth scaling	Needs pipeline logic	2 signed contracts / LOIs
AI cost per prompt	—	Can scale faster than revenue	< €0.005/prompt

Full detail in the Validation Targets tab and the two review documents in the data room above.

Secure data room

Documents

Behind PIN + 2FA. Production access is logged per-file (Cloudflare Access / SSO + MFA).

📊 Rebuilt financial model (XLSX) 📑 Review & assumptions (DOCX) 📑 Industry benchmarks vs. assumptions (DOCX) 📄 Pitch deck (PDF)

🛠️ Open Admin MIS console →

The problem

Healthcare was designed for male biology

Men run on a ~24-hour hormonal cycle; women on ~28 days across four phases. Generic nutrition ignores this — and women pay the cost.

⚠️

Higher adverse drug reactions

Research & dosing skew male, raising risk for women.

⏳

Later diagnoses & delayed care

Women's symptoms are under-recognized and under-served.

🔬

Left to self-experiment

No guidance on food + training across cycle phases.

The science

Different biology. Same nutrition?

The "one-size-fits-all" diet ignores the 28-day cycle. NutriSync syncs food & training to each of the four phases.

Menstrual

Days 1–5

Iron, warming foods, hydration. Gentle movement & rest.

Follicular

Days 6–13

Fresh foods, complex carbs, protein. Build intensity & strength.

Ovulatory

Days 14–16

Anti-inflammatory, fiber. Peak performance & HIIT.

Luteal

Days 17–28

Magnesium, complex carbs. Steady-state, wind down.

The mission

Building scalable women's health infrastructure

Aligned to UN SDG 3 (Good Health & Well-being) and SDG 5 (Gender Equality).

🌿

Preventative nutrition

Personalized nutrition aligned with hormonal phases.

📊

Optimization engine

Symptom tracking & optimization engine.

🏥

Digital infrastructure

For an underfunded healthcare segment.

🔬

Closing the data gap

Real-world cycle data + rising menstrual-health literacy.

Value proposition

The adaptive cycle intelligence

NutriSync transforms menstrual cycle data into actionable, personalized guidance that adapts in real time to your biology and lifestyle. Personalized · science-backed · holistic · private by design.

Cycle Sync Score (CAS)

A real-time 0–100 daily alignment score.

Phase Detection Confidence 15%
Physiological Biomarker Signals 25%
Nutrition Alignment 30%
Fitness / Recovery Alignment 20%
Logging Consistency 10%

Cycle Stability Score (CSS)

Improvement across cycles, not just today.

Energy Stability Improvement 45%
Mood Stability Improvement 45%
PMS Symptom Stability 10%

The scoring IP is implemented & unit-tested in packages/core/cas.mjs.

Market

Menstrual health apps market

A fast-growing, specific segment — not the broad FemTech number. Cycle-synced nutrition is the wide-open wedge within it.

$5.07Bmarket by 2030

20.24%CAGR

'20

'22

'24

'26

'28

$5.07B'30

Beachhead — Spanish market

€1.4Bn

TAM

Spain's women's-health app + corporate wellness — everyone who could pay for cycle/hormonal wellbeing tech.

€168M

SAM

2M Spanish women already paying for digital health, plus B2B wellness buyers.

€1.2M

SOM

Spain share of the projected 400k users.

Sources: INE 2024 · Heraldo 2023 · Agencia SINC 2023 · European Psychiatry 2022.

The NutriSync difference

From period tracking to cycle nutrition at scale

What it takes	Generic apps	Content apps	NutriSync
Science-backed cycle-sync framework	◐	◐	●
Ethical data & privacy design	◐	◐	●
Integrated cycle, nutrition & fitness plans	◐	◐	●
AI personalization	—	◐	●
Social & community features	●	◐	●
Direct-to-consumer	●	●	●
Clinician-partnered distribution	—	—	●
Institutional ATL outreach	—	—	●
TTL data & insight loop	—	—	●

● core capability◐ partial— solved separately

Traction

On track to launch MVP to 170 beta users in Q3 2026

🔬 Customer validation

160 interviews · 96% report cycle impacts performance · 88% want a personalised solution.

💶 Early revenue

€420+ from paid events · 32+ total paying attendees.

📣 Demand

130 women waitlist · 30k organic views · university + corporate partnerships.

Runner-upIE Venture Lab (200+ startups)

2nd placeIE Entrepreneurship Summit (60)

2nd placeESADE Shark Tank (100+)

Backed by IE University, Loadmill, Women in Banking, Bolt.Earth, Viasat.

Business model

Four revenue streams

Subscription first, B2B as the multiplier, clinical partnerships as the moat.

B2C Basic — €4.99/mo

Cycle-aware nutrition + fitness plans. Penetration pricing to maximise Y1 volume.

B2C Premium — €12.99/mo

Launches month 13. AI personalised cycle plans + clinical consultation booking. ~160% more revenue per user.

B2B Corporate — €3.99/mo

Corporate wellness contracts. Avg 150 employees = €5,985/yr per contract; renews at €5.99.

Clinical + Events + Brand — €500–8K

Clinic referral fees, paid workshops/masterclasses, and founder brand partnerships.

13.6xLTV/CAC organic

2.85xLTV/CAC paid

€4.20CAC organic

€20CAC paid

88%gross margin Y3

1–4.7mopayback

Go-to-market

From waitlist to global platform

M1–12

Launch & first data · target 3.5K+ users, €20K MRR

Vercel pilot → App Store launch (M3) · CTO hired, first €4.99 subs · paid social from M4 (€3–5k/mo) · Apple HealthKit (M4–6) · AI personalisation engine (M6) · 2 clinical partners signed (B2B pilot) · GDPR health-data architecture.

M13–24

Active deep tech · target 20K+ users, €80k MRR

Conversational AI companion (M13) · Premium €12.99 live · Oura Ring integration (M15) · predictive hormonal modelling (M20) · UK + Australia + Portugal · 10 B2B, 5 clinical partners · perimenopause tracking.

M25–36

Hormonal health · target 80K+ users, €200K MRR

CGM integration · at-home hormone test-kit integration · menopause as dedicated product tier · population-health data layer · US launch, AI model matures · academic publication of clinical AI findings.

Founder social

4K followers today → 50K+ by Y3. Zero marginal CAC.

Paid social M4+

€3–5k/mo IG & TikTok · CAC €6–8 (~50% below industry) · 375–625 new users/mo.

B2B & clinical

1 × 150-employee contract = 150 users instantly · 50 patient conversions/clinic/mo · 5 contracts = 750 B2B users Y1.

Events & community

Already revenue-generating · 40–60% convert to subscribers · 2 events = €500–1k/event.

Capital efficient growth

Deck (Conservative) headline figures

€902K

Y3 annual revenue

ARR €1.04M annualised.

15.5K+

Y3 paying users

Deep-tech Y2+ impact.

M35

Reach profitability

Breakeven around quarter 11.

Note: the rebuilt financial model (above) deliberately makes the Conservative case less aggressive than these deck figures — ~5.9K paying users / ~€316K revenue by Y3 — and treats unproven assumptions as validation targets. Use the rebuilt model for diligence; the deck figures reflect the prior projection.

Deep tech rollout

Four deep-tech layers, sequenced by funding stage

1 · Adaptive AI engine

Now → M6.

2 · Conversational AI Nutri

M13 (Premium).

3 · Predictive hormonal modelling

Mid-stage.

4 · Lab test + CGM

Series A, Y3.

🛡️ Data moat

3+ months of tracking creates a unique hormonal data signature. Competitors would need ~5 years to build it.

🩺 Clinical moat

Clinical partnerships take 12–18 months; a generic app can't replicate branded clinical content in 6.

📡 Distribution moat

Founder social channels = 50K+ combined audience, zero-marginal-CAC advantage in the exact target demographic.

Wearables strategy

An Apple Watch becomes a hormonal health advisor — €0 hardware

Access 100M+ existing devices, no hardware to build.

Apple Watch + HealthKit

M4. HR, HRV, sleep, activity, skin temp, blood oxygen. 60% of target own one; API free, 4–6 wks dev.

Google Fit + Wear OS

M4. Spain & Australia (Android 70%+), shared codebase, low marginal cost.

Oura Ring

Y3. Skin-temp trend, HRV readiness, sleep — automatic cycle prediction.

CGM — Dexcom / Libre

Y3. Blood glucose across the cycle; most complete hormonal-nutrition picture.

50%churn reduction (connected)

12.4xLTV/CAC wearable users

€8KHealthKit dev, payback <2mo

FREEHealthKit, Oura, Google Fit APIs

Long-term expansion

Menopause — a bigger, almost-empty opportunity

M18

Perimenopause tracking (soft launch)

M22

HRT interaction guidance layer

Menopause as a dedicated product tier + B2B workplace programme

$22.7B

Global menopause market by 2028

7% CAGR. Same infrastructure, different life stage, higher ARPU.

1M+

Women entering menopause / yr (US)

Proven demand, almost no tech supply.

~12

App solutions today

Mostly symptom trackers — no integrated nutrition layer.

The ask

Join our growth journey

Raising

€350K

18-month runway

Tech infrastructure

34% · €119K

Team stipends

26% · €91K

Marketing & paid social

20% · €70K

Clinical partnerships

12% · €42K

Legal, ops & admin

8% · €28K

Month 3

App live & first revenue

Month 9

4000+ paying users

Month 13

Seed round closes

Team

Built by women, for women

Pilar Gonzalez

CEO · Co-Founder

Strategy consulting & research

Lucia Cebrian

COO · Co-Founder

UX/UI & product development

Maria Paula Garzon

CMO · Co-Founder

Branding & marketing strategy

Advisory board

Juan Jose Gonzalez

Technology & Digital Transformation — CTO of CHUBB. Supports digital infrastructure, scalability and AI-driven UX.

Kanika Pandey

AI & Growth Strategy — CRO of Global Sales at Loadmill. Advises on scaling growth.

Clara Miranda

Strategy & Brand Innovation — Former Global Innovation Lead at ING.

Constanza Ramirez Milli

Clinical Nutrition — ensures the nutritional approach is science-based.

Beatriz Serrano Sordo

Finance & Governance — Senior Credit Analyst at AXA. Financial oversight & funding strategy.

NutriSync provides wellness & educational guidance, not medical advice. Confidential — for invited investors, advisors, and team only.

NUTRISYNC 🪶

Admin console

Internal MIS & business tracking. Staff access only.

Demo code: admin2026. Production uses Cloudflare Access + SSO + MFA, RBAC (backlog G1).